Intercept Pharmaceuticals, Inc.

DEUTSCHE BANK AG\

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/24/2023

Shares

14,755

Value ($000)

274

Weight

0.0%

2013 Q4 - 2023 Q3 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/24/2023	274	0.0%	14,755	9/30/2023
2023 Q2	8/14/2023	249	0.0%	22,499	6/30/2023
2023 Q1	5/15/2023	3,560	0.0%	265,057	3/31/2023
2022 Q4	2/13/2023	1,128	0.0%	91,225	12/31/2022
2022 Q3	11/14/2022	1,156	0.0%	82,871	9/30/2022
2022 Q2	8/11/2022	894	0.0%	64,760	6/30/2022
2022 Q1	5/13/2022	248	0.0%	15,241	3/31/2022
2021 Q4	2/16/2022	282	0.0%	17,333	12/31/2021
2021 Q3	11/4/2021	382	0.0%	25,782	9/30/2021
2021 Q2	8/11/2021	2,366	0.0%	118,509	6/30/2021
2021 Q1	5/13/2021	648	0.0%	28,115	3/31/2021
2020 Q4	2/16/2021	1,803	0.0%	72,980	12/31/2020
2020 Q3	11/12/2020	12,811	0.0%	308,989	9/30/2020
2020 Q2	8/13/2020	14,765	0.0%	308,163	6/30/2020
2020 Q1	5/14/2020	22,726	0.0%	360,960	3/31/2020
2019 Q4	2/14/2020	61,026	0.0%	492,478	12/31/2019
2018 Q3	12/21/2021	61,054	—	483,174	9/30/2018
2018 Q2	4/21/2020	30,513	—	363,645	6/30/2018
2014 Q1	5/15/2014	2,584	0.0%	7,839	3/31/2014
2013 Q4	2/24/2014	96	0.0%	1,417	12/31/2013